U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.

U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.

Item
http://www.wikidata.org/entity/Q33364668
The role of c-kit and imatinib mesylate in uveal melanoma.Fibrotic and sclerotic manifestations of chronic graft-versus-host diseasePhase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignanciesPeriorbital edema secondary to imatinib mesylate.Phase II cancer prevention clinical trialsDysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesPopulation pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease.Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability.BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.Molecular mechanisms of lung-specific toxicity induced by epidermal growth factor receptor tyrosine kinase inhibitors.Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies.RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.Protein tyrosine kinase panel as a tool for anticancer drug design.Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.
P2860

U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.

Item
http://www.wikidata.org/entity/Q33364668
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
U.S. Food and Drug Administrat ...... ted approval to full approval.
@ast
U.S. Food and Drug Administrat ...... ted approval to full approval.
@en
type
label
U.S. Food and Drug Administrat ...... ted approval to full approval.
@ast
U.S. Food and Drug Administrat ...... ted approval to full approval.
@en
prefLabel
U.S. Food and Drug Administrat ...... ted approval to full approval.
@ast
U.S. Food and Drug Administrat ...... ted approval to full approval.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
U.S. Food and Drug Administrat ...... ted approval to full approval.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-05-0722
P407
P433
P478
P577
P698
P921